Literature DB >> 16495942

Expanding insights of mitochondrial dysfunction in Parkinson's disease.

Patrick M Abou-Sleiman1, Miratul M K Muqit, Nicholas W Wood.   

Abstract

The quest to disentangle the aetiopathogenesis of Parkinson's disease has been heavily influenced by the genes associated with the disease. The alpha-synuclein-centric theory of protein aggregation with the adjunct of parkin-driven proteasome deregulation has, in recent years, been complemented by the discovery and increasing knowledge of the functions of DJ1, PINK1 and OMI/HTRA2, which are all associated with the mitochondria and have been implicated in cellular protection against oxidative damage. We critically review how these genes fit into and enhance our understanding of the role of mitochondrial dysfunction in Parkinson's disease, and consider how oxidative stress might be a potential unifying factor in the aetiopathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495942     DOI: 10.1038/nrn1868

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  303 in total

1.  Hyperexcitable substantia nigra dopamine neurons in PINK1- and HtrA2/Omi-deficient mice.

Authors:  Matthew W Bishop; Subhojit Chakraborty; Gillian A C Matthews; Antonios Dougalis; Nicholas W Wood; Richard Festenstein; Mark A Ungless
Journal:  J Neurophysiol       Date:  2010-10-06       Impact factor: 2.714

2.  Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.

Authors:  Judith Eschbach; Björn von Einem; Kathrin Müller; Hanna Bayer; Annika Scheffold; Bradley E Morrison; K Lenhard Rudolph; Dietmar R Thal; Anke Witting; Patrick Weydt; Markus Otto; Michael Fauler; Birgit Liss; Pamela J McLean; Albert R La Spada; Albert C Ludolph; Jochen H Weishaupt; Karin M Danzer
Journal:  Ann Neurol       Date:  2014-12-19       Impact factor: 10.422

3.  Developmental exposure to organophosphates triggers transcriptional changes in genes associated with Parkinson's disease in vitro and in vivo.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2011-09-28       Impact factor: 4.077

Review 4.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 5.  S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration.

Authors:  Tomohiro Nakamura; Piotr Cieplak; Dong-Hyung Cho; Adam Godzik; Stuart A Lipton
Journal:  Mitochondrion       Date:  2010-05-04       Impact factor: 4.160

6.  Enhanced hippocampus-dependent memory and reduced anxiety in mice over-expressing human catalase in mitochondria.

Authors:  Reid H J Olsen; Lance A Johnson; Damian G Zuloaga; Charles L Limoli; Jacob Raber
Journal:  J Neurochem       Date:  2013-03-06       Impact factor: 5.372

7.  The mitochondrial antioxidants MitoE(2) and MitoQ(10) increase mitochondrial Ca(2+) load upon cell stimulation by inhibiting Ca(2+) efflux from the organelle.

Authors:  Sara Leo; György Szabadkai; Rosario Rizzuto
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

9.  Therapeutic vitamin A doses increase the levels of markers of oxidative insult in substantia nigra and decrease locomotory and exploratory activity in rats after acute and chronic supplementation.

Authors:  Marcos Roberto de Oliveira; Roberta Bristot Silvestrin; Tadeu Mello e Souza; José Cláudio Fonseca Moreira
Journal:  Neurochem Res       Date:  2007-08-22       Impact factor: 3.996

10.  JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death.

Authors:  Won-Seok Choi; Hyung-Wook Kim; Zhengui Xia
Journal:  Toxicology       Date:  2014-12-09       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.